BMPR2-IN-1 (Compound 8a) is a BMPR2 inhibitor with an IC50 of 506 nM and a KD of 83.5 nM. It is applicable in research studies related to pulmonary arterial hypertension, Alzheimers disease, and cancer.
Target:
TGF-beta/Smad
* VAT and and shipping costs not included. Errors and price changes excepted
